Features

Features: 

Jedd Wolchok speaks to Asco Daily News about the PD1 Pathway and the activity of novel agent Nivolumab as a potential predicative target.


Host: 

The Ludwig Center is based at Memorial Sloan Kettering Cancer Center, the world's oldest and largest private cancer center.
 

MSK center

News: 

Jedd Wolchok speaks to Asco Daily News about the PD1 Pathway and the activity of novel agent Nivolumab as a potential predicative target.


Host: 

The Ludwig Center is based at Memorial Sloan Kettering Cancer Center, the world's oldest and largest private cancer center.
 

Ludwig Center at MSK
1275 York Avenue, Box 212
New York, NY, us, 10065
T 646 888 3165
F 646 422 0453

Our Center at Memorial Sloan Kettering Cancer Center (MSK) is building on transformative advances in cancer immunology and immunotherapy, which, to a large degree, have come from preclinical and clinical studies conducted over the years at the Center and MSK. We are actively pursuing this original goal: to harness the knowledge of fundamental mechanisms operating within the immune system to develop novel cancer and metastasis treatments.

Ludwig Center at MSK
1275 York Avenue, Box 212
New York, NY, us, 10065
T 646 888 3165
F 646 422 0453